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Introduction: Type 2 diabetes mellitus is a chronic disease that is causing enormous economic and 
social costs. It is characterized by many microvascular and macrovascular complications, such as 
heart attack, stroke, retinopathy, nephropathy, neuropathy, etc. Such complications can cause severe 
limitations and decrease the quality of life. The objective of this study was to assess the effect of type 
2 diabetes mellitus on the quality of life using the EQ-5D-5L questionnaire, taking into account 
cardiovascular complications (heart attack, hospitalization due to angina pectoris, stroke, 
hospitalization due to heart insufficiency, transient ischemic attack, coronary revascularisation), 
complications of diabetes (microalbuminuria, renal failure, retinopathy, and neuropathy), and 
demographic characteristics (age, gender, body mass index, height, and weight). 
Materials and Methods: This cross-sectional study included 484 participants with type 2 diabetes 
mellitus. Quality of life was estimated by the EuroQol instrument EQ-5D-5L and visual analogue scale 
(VAS). The following complications related to type 2 diabetes were taken into account: heart attack, 
hospitalization due to angina pectoris, stroke, hospitalization due to heart insufficiency, transient 
ischemic attack, coronary revascularization, microalbuminuria, renal insufficiency, retinopathy, and 
neuropathy. 
Results: The mean value of the EQ index was 0.895, with the value of -0.59 as the lowest, and 1.0 as 
the highest quality of life of the study patients. Multivariate linear regression model showed that heart 
attack, hospitalization due to unstable angina pectoris, retinopathy, and neuropathy significantly 
decreased the quality of life of the study participants (p<0.05). Spearman's correlation showed that 
there was a significant correlation between age, height, duration of type 2 diabetes, body mass index, 
and the EQ index (p<0.001). 
Conclusion: The results suggest that type 2 diabetes complications, such as heart attack, 
neuropathy, retinopathy, and hospitalization due to unstable angina pectoris significantly decrease 
the quality of life of type 2 diabetes mellitus patients (T2DM). 
(Mehović S, Janković S, Tafi Z. Quality of Life Assessment in Type 2 Diabetes Patients With 
Cardiovascular and/or Diabetic Complications. SEEMEDJ 2021; 5(1); 75-88) 
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Introduction 
There are two types of methods that can be 
used for measuring health utilities: direct and 
indirect. So far, several direct methods have 
been developed, such as: 1) standard gamble: 
reflects the assessment of an individual’s 
preference or valuation of their current QoL by 
quantifying tolerance to risk toward an ultimate 
bad outcome as a gamble for achieving a 
perfect state of health (1); 2) time trade-off: 
individuals are asked to choose between living 
in their current impaired health state for 10 years 
or living for a shorter period with perfect health 
(2); and 3) visual analogue scale: introspective 
scaling with a rating scale from 0 to 100, where 
a patient has to choose one number on this scale 
that correctly reflects his/her quality of life (3). 
On the other hand, there are many indirect 
methods which have already been validated, 
and they can be generic (e.g. the EQ-5D 
questionnaire) or specific for certain diseases 
(e.g. FACT-G). Indirect methods do not give 
immediate values for health utilities; rather, an 
algorithm must be developed for a 
transformation of answers to utility values (3).  
T2DM is recognized as one of the most common 
diseases worldwide, which affects every country 
and different groups of people, regardless of the 
demographic and socio-economic status (4). 
Microvascular and macrovascular complications 
are almost inevitable during the course of the 
disease. The most common microvascular 
complications are diabetic nephropathy, 
neuropathy, and retinopathy, while the most 
common macrovascular complications are 
peripheral vascular disease, myocardial 
infarction, stroke, and congestive heart failure 
(5). Quality of life assessment in patients with 
T2DM is important for the development of 
progressive simulation models used for a long-
term assessment of the cost and effectiveness 
of interventions for the treatment of type 2 
diabetes and prevention of accompanying 
complications. Assessing the utility is the main 
prerequisite for determining the QALY and it is 
very important to include participants with a full 
spectrum of characteristics and health 
complications (retinopathy, neuropathy, 
nephropathy, etc.) (6). Zhang et al. conducted a 
study in the United States of America (USA) on 
7327 participants with T2DM. The average EQ 
index (utility) in this study was 0.80. They 
concluded that participants without 
complications of type 2 diabetes, cardiovascular 
risk factors, and other comorbidities, who were 
not obese and who had an average income of 
over USD 40,000, had a better average EQ index, 
reaching 0.92 (7). Arifin et al. also concluded that 
T2DM patients with macro/microvascular 
complications have a lower QoL (0.77-0.79) than 
those without such complications (0.80). Also, if 
they have more than two complications, their 
QoL is even lower (0.74) (8). Pham et al. showed 
on 214 T2DM patients that those with diabetic 
retinopathy have a lower QoL (0.92) compared to 
those who have diabetic heart disease (0.94) or 
nephropathy (0.93) (9). A study in Japan showed 
that T2DM patients with more serious 
microvascular complications have a lower QoL 
compared to those who have one or no 
complications. Patients with proliferative 
retinopathy had a QoL of 0.85, while those with 
pre-proliferative retinopathy had a better quality 
of life (0.93). Also, those suffering from stage four 
nephropathy had a QoL of 0.78, while the QoL of 
those suffering from stage one nephropathy was 
as high as as 0.93 (10). There are also other 
studies showing that patients with complications 
of type 2 diabetes not only live shorter, but their 
quality of life is also lower (11,12). However, there 
is a paucity of studies using the EQ-5D-5L 
questionnaire for a quality of life assessment in 
T2DM patients, and their quality estimates vary 
within a broad range from 0.74 to 0.92 (13-17). 
EQ-5D-5L questionnaire is a relatively new 
preference-based instrument with lower ceiling 
effects and a better sensitivity compared to the 
EQ-5D-3L. Those two questionnaires are most 
commonly used in clinical and outcomes 
research (18).  
The aim of this study was to assess the effect of 
type 2 diabetes mellitus on the quality of life 
using the EQ-5D-5L questionnaire, taking into 
account cardiovascular complications (heart 
attack, hospitalization due to angina pectoris, 
stroke, hospitalization due to heart insufficiency, 
transient ischemic attack, and coronary 
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revascularisation), complications of diabetes 
(microalbuminuria, renal insufficiency, 
retinopathy, and neuropathy) and demographic 
characteristics (age, gender, body mass index, 
height, weight, smoking status, duration of 
diabetes, and education level). 
Materials and Methods  
Study population 
This was a cross-sectional study, approved by 
the Ethics Committee of the Public Institution 
Health Center of Sarajevo Canton, which 
included 509 patients from Bosnia and 
Herzegovina. Between December 2019 and 
June 2020, 361 patients in total were interviewed 
in person, while 148 patients were interviewed 
online. Interviews in person were conducted at 
several health centers in Sarajevo, such as the 
Vrazova, Omer Maslić, and Kumrovec Health 
Center, (urban areas) and Ilijaš Health Centre 
(rural areas). After reviewing the answers, 484 
participants were eligible for the final analysis, 
while 25 were excluded due to incompleteness. 
Criteria for inclusion in the study were: diagnosis 
of T2DM in the patient file, age >18 years, and 
signed informed consent for participation in the 
study. Criteria for non-inclusion or exclusion 
from the study were: persons under the age of 
18, not signing the informed consent, pregnancy 
and/or a diagnosis of a major psychiatric 
disorder in the patient file. 
Questionnaire 
In order to collect the patient information, a 
tripartite questionnaire was used, assessing the 
demographic/socio-economic characteristics 
(age, gender, height, weight, education level, 
duration of type 2 diabetes, and smoking status), 
quality of life by the EQ-5D-5L questionnaire and 
by the visual analogue scale (VAS), and 
cardiovascular and diabetic complications. 
The following events were taken into account, 
reflecting the complications of type 2 diabetes: 
heart attack, hospitalization because of unstable 
angina pectoris, stroke, hospitalization because 
of heart failure, transient ischemic attack, 
repeated coronary revascularization, 
microalbuminuria, renal insufficiency, 
neuropathy, and retinopathy. 
EQ-5D-5L questionnaire 
The EQ-5D-5L is a generic (19-23) questionnaire 
validated for the assessment of the quality of life 
of individuals with various health conditions. It 
assesses five dimensions: mobility, self-care, 
usual activities, pain/discomfort, and 
anxiety/depression. Each dimension is ranked at 
five levels: no problems – 1, slight problems – 2, 
moderate problems – 3, severe problems – 4, 
and extreme problems – 5. After filling in the 
questionnaire, depending on the patients’ 
answers, the five dimensions are combined in a 
five-digit number that describes the patient’s 
health state. The five-digit code is further 
converted to an EQ index using an automatic 
calculator (24) and the results from our study 
were checked using the guidelines from a 
validation study conducted in Poland (25). Since 
there was no local set of values that had been 
validated, Poland was selected due to its 
cultural similarity with Bosnia and Herzegovina. 
The EQ index ranged between -0.59 (the lowest 
QoL) and 1 (the highest QoL). The EQ-VAS scale 
was used together with the EQ-5D-5L 
questionnaire (26).  
A validated Croatian version of EQ-5D-5L was 
used in our study, since the official language of 
Bosnia and Herzegovina is the 
Bosnian/Croatian/Serbian (BHS) language. A 
laptop/desktop version of the questionnaire 
was obtained from EuroQol. 
Statistical analysis 
The results were described by frequencies and 
proportions for categorical values, and by the 
arithmetic mean and standard deviation for 
continuous values (or by the median with 
interquartile range, if the data were not normally 
distributed). Normality of data distribution was 
tested by the Shapiro Wilk and Kolmogorov-
Smirnov tests. Nonparametric tests, such as the 
Mann-Whitney U test, the Kruskal-Wallis test, 
and non-parametric ANOVA, were used for 
comparison of the study groups. Impact of 
health complications, demographic 
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characteristics, and health state were assessed 
by a multivariate linear regression model after 
confirming that the following assumptions were 
satisfied: linear relationship, independence, 
homoscedasticity and normality (27). Results 
with α ≤ 0.05 or within the 95% confidence 
interval were considered statistically significant. 
SPSS for Windows (version 21.0, SPSS Inc, 
Chicago, Illinois, USA) and Microsoft Excel 
(version 11.0, Microsoft Corporation, Redmond, 
WA, USA) were used for statistical analysis. 
Results 
The final analysis included 484 participants 
(28.7% men and 71.3% women). Mean duration of 
T2DM was 8.18 ± 7.08 years and the majority of 
participants were taking only oral antidiabetic 
drugs (55.8%) or oral drugs in combination with 
subcutaneous medication (41.7%). Other 
demographic characteristics of the study 
participants are shown in Table 1. More detailed 
results are shown in Supplement 1. 
Table 1. Main demographic/socioeconomic characteristics of study participants (n=484). 
Characteristic Minimum Maximum Mean Median Std. deviation 
Age (years) 20 92 52.68 53 12.11 
Body weight (kg) 47 186 89.00 88 18.27 
Height (m) 1.45 2.00 1.70 1.69 0.08 
Duration of type 2 diabetes (years) 0.02 40 8.18 6.00 7.08 
Body Mass Index (BMI) (kg/m2) 18.36 55.54 30.70 30.12 5.68 
 










Yes, active smoker 
No, never smoked  
No, stopped smoking 
Type of therapy 
Oral 




















The majority of participants did not have 
problems with mobility (61%), but 1% of them had 
extreme problems. Also, most of them did not 
have problems with self-care (79.5%) and usual 
activities (62.8%). On the other hand, a high 
percentage of participants had slight or 
moderate problems with pain/discomfort and 
anxiety/depression. More details about the 
participants’ answers are shown in Table 2..
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Table 2. Distribution of the EUROQOL 5D-5L answers given by study participants (n=484) according 











Mobility 295 (61%) 76 (15.7%) 85 (17.6%) 23 (4.8%) 5 (1%) 
Self-care 385 (79.5%) 45 (9.3%) 42 (8.7%) 8 (1.7%) 4 (0.8%) 
Usual activities 304 (62.8%) 86 (17.8%) 73 (15.1%) 15 (3.1%) 6 (1.2%) 
Pain/discomfort 214 (44.2%) 141 (29.1%) 100 (20.7%) 25 (5.2%) 4 (0.8%) 
Anxiety/depression 201 (41.5%) 137 (28.3%) 109 (22.5%) 31 (6.4%) 6 (1.2%) 
 
Using the EQ-VAS scale, the participants 
indicated how they felt at the moment of the 
interview. The minimum value was 5 and 
maximum was 100, with 70.40 (SD 20.49) points 
as the average value. The lowest EQ index was -
0.59 and the highest one was 1.0, with 0.895 (SD 
0.183) on average (Table 3). 
Table 3. Scores on EQ VAS scale and EQ index of study participants (n=484) 
 Minimum Maximum Mean Median Std. deviation Kolmogorov-Smirnov 
EQ VAS scale 5 100 70.40 75 20.49 p = 0.000 
EQ INDEX -0.59 1.00 0.895 0.952 0.183 p = 0.000 
 
Most of the participants did not have any 
cardiovascular/diabetic complications (46.90%) 
or had just one (23.97%). The most common 
complications were neuropathy (31.4%) and 
retinopathy (28.9%), while microalbuminuria 
(2.7%) and stroke (3.1%) were the rarest. The most 
common events occurring due to cardiovascular 
complications were hospitalization due to 
unstable angina pectoris (8.3%) or heart attack 
(8.1%). Renal failure was reported in 9.1% of the 
cases. More details can be seen in Supplements 
2 and 3. 
Spearman's correlation showed that there was a 
significant correlation between age, height, 
duration of type 2 diabetes and BMI (p<0.001) 
with the EQ index. There was a negative 
correlation between BMI, age and duration of 
type 2 diabetes and the EQ index (Table 4). 
Table 4. Correlation between demographic characteristics and EQ index of study participants (n=484) 
 Spearman's correlation coefficient p* 
Height 0.223 0.000 
Body weight 0.019 0.675 
BMI -0.106 0.000 
Age -0.254 0.000 
Duration of type 2 diabetes -0.228 0.000 
 
We analysed whether gender (Mann-Whitney U 
test) and level of education/smoking status 
(Kruskal-Wallis test) influenced the EQ index 
values. The results showed a significant 
influence of gender (U=19526.500, p=0.001) and 
level of education (Kruskal-Wallis H 9.949, 
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p=0.041) on the EQ index. Smoking status did not 
affect the quality of life (Kruskal-Wallis H 1.082, 
p=0.582). 
Multivariate linear regression was used to 
determine the effects of study variables on the 
quality of life. The EQ index was appointed as a 
dependent variable, and gender, age, level of 
education, weight, height, BMI, duration of type 
2 diabetes, and cardiovascular/diabetic 
complications were used as independent 
variables in the analysis. Results showed that 
four complications – neuropathy, heart attack, 
stroke, and hospitalization because of unstable 
angina pectoris – had the greatest impact on the 
quality of life. These four dependent variables 
explained 49.3% of model variance (R=0.493, 
F=34.550, p=4.98*10-25) (Table 5).
Table 5. Effects of certain diabetic complications on the QoL of study participants (n=484): results of 
multivariate linear regression 
Model B Sig. 
95% confidence interval for B 
Lower bound Upper bound 
















































This cross-sectional study conducted in Bosnia 
and Herzegovina investigated the association 
between type 2 diabetes, its complications and 
the QoL using the EQ-5D-5L questionnaire. EQ-
5D-5L is an easy-to-understand and validated 
generic questionnaire for a QoL assessment (28). 
BMI, age, and duration of T2DM showed a 
negative correlation with the QoL, meaning that 
older patients, with a higher BMI and longer 
duration of illness had a lower QoL. The results 
also showed that most of the participants did not 
have problems with mobility or self-care, but 
they had problems with pain/discomfort and 
anxiety/depression, which is similar to previous 
studies. Regarding T2DM patients, Luk et al. 
reported that more patients had problems with 
pain/discomfort (24.8%) and anxiety/depression 
(20.3%) than with other dimensions of the EQ-5D-
5L questionnaire (29). In several other studies, it 
has been shown that pain/discomfort was the 
most affected domain in patients (30-32). Such 
results may be due to the fact that the most 
common T2DM complication was neuropathy, 
which may cause pain/discomfort. Also, T2DM 
can change mood and lower self-esteem, 
leading to anxiety and depression (33). A study 
by Parik and Patel showed that anxiety and 
depression have a stronger impact on younger 
T2DM patients (34). A CODE-2 study on 1,371 
T2DM participants showed that anxiety and 
depression were increased at a younger age and 
SEEMEDJ 2021, VOL 5, NO. 1 Life Quality in Diabetes Mellitus 
81 Southeastern European Medical Journal, 2021; 5(1) 
 
then decreased with age (35). Auslli et al. 
suggested that patients with T2DM should be 
advised carefully about the importance of foot 
care and exercise. They concluded that physical 
exercise is a very important determinant of 
positive clinical outcomes of T2DM and it is 
associated with better HbA1C levels, a lower 
BMI, fewer diabetic complications and a higher 
QoL (36). 
Our results also showed that the QoL is 
dependent on gender, age, and education level, 
where females, older participants and those with 
a lower level of education had a lower QoL. 
Smoking status and weight did not have a 
significant impact on the QoL. A study in Korea 
showed that age is an important factor of the 
QoL of patients with T2DM and that younger 
participants had a better QoL, most likely 
because they had T2DM for a shorter period of 
time and fewer health-related complications 
(37). Stojanović et al. also showed that lower 
level of education was highly related to lower 
QoL. Possible mechanisms include insufficient 
access to healthcare services, unhealthy habits, 
poor mental health, and higher frequency of 
complications (38). A study in Denmark, involving 
2419 patients with T2DM, showed that poor 
socioeconomic status, age, female gender, 
presence of comorbidity, poor glycemic control 
and lower level of education were associated 
with depressive episodes and lower QoL of 
T2DM participants (39). There have been many 
other studies showing that these factors are 
strong determinants of the QoL (37-50).  
Most of the participants did not have any 
diabetic complications (46.90%). Among those 
who had some of the complications, the most 
common were neuropathy (31.4%) and 
retinopathy (28.9%), while microalbuminuria and 
stroke were the rarest. Data from the American 
Diabetes Association shows that 75-80% of 
adults with diagnosed DM will ultimately die 
from cardiovascular disease due to chronic 
macrovascular complications (41). Microvascular 
and macrovascular complications of T2DM put a 
great burden on every healthcare system, even 
in developed countries like the USA. However, 
this is not the only problem. Many studies have 
shown that patients with T2DM who have one or 
more diabetic complications also have a 
significantly lower QoL compared to those who 
do not have T2DM-related complications (42-
46).  
In our study, the values of the VAS scale varied 
from 5 to 100, with 70.40 as the average value. 
After converting the scores to the EQ index, the 
lowest value was -0.59 and the highest was 1.0., 
with 0.895 as the average value. According to 
Mlitt et al., a negative index is possible when 
researchers use the EQ-5D-5L questionnaire 
(40). It suggests that the health state of these 
participants is deemed to be worse than death. 
The VAS scale score can vary between different 
group of participants. A Norwegian study of 
T2DM patients showed a mean EQ index of 0.85 
(51), while an Iranian study reported an even 
lower average value (0.70) (52).  
A multivariate linear regression model based on 
our data showed that factors such as 
neuropathy, heart attack, stroke, and 
hospitalization due to angina pectoris are strong 
predictors of the QoL, which is a finding 
congruent with the results of previous studies 
analysing patients with diabetes type 2. A 
univariate and multivariate regression analysis 
by Stojanović et al. also showed that angina 
pectoris, heart failure, diabetic retinopathy, and 
diabetic nephropathy are factors that impact the 
QoL of T2DM patients the most (38). A study in 
China, which was conducted on 1,275 patients 
with T1DM, showed that the presence of any of 
the four major diabetic complications (heart 
disease, stroke, end-stage renal disease, sight-
threatening diabetic retinopathy) have a 
significant impact on the QoL (48). The United 
Kingdom Prospective Diabetes Study showed 
that utilities are significantly reduced in T2DM 
patients who have serious complications, like 
end-stage renal disease, blindness, stroke or 
heart attack (50). There is a plethora of other 
studies showing that T2DM patients with 
complications have a decreased QoL compared 
to T2DM patients without such complications 
(12,49,51,53,54).  
 Our study has certain limitations. Firstly, 
the EQ-5D-5L questionnaire was not previously 
validated in Bosnia and Herzegovina. Therefore, 
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the transformation of raw scores to the EQ index 
had to be based on the results from another 
population that is as similar as possible to the 
Bosnian population in terms of culture (the 
Polish population), which still creates a certain 
potential for bias. Secondly, the sample used in 
the study was not ideally balanced in regard to 
frequency and severity of type 2 diabetes 
complications, which could have led to an 
overestimate of the EQ scores. 
Conclusions 
Our study gave an overview of average EQ index 
values in the population of diabetes type 2 
patients from Bosnia and Herzegovina, and 
showed a prevailing influence of diabetic 
complications on the quality of life, which could 
be used for further pharmacoeconomic 
analyses. Demographic characteristics, such as 
the BMI, age and duration of T2DM were 
negatively correlated with the QoL, meaning 
that patients with a higher BMI, who are older 
and have suffered from the illness for a longer 
period of time, had a lower QoL. Neuropathy, 
heart attack, stroke, and hospitalization due to 
unstable angina had the greatest impact on the 
QoL in T2DM patients. 
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SUPPLEMENTS 
Supplement 1. EQ Index mean values (n=484) 
 Number of 
patients 
(n=484) 



















































































Yes, active smoker 
No, never smoked 
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Supplement 2. Type 2 diabetes - related complications 










Hospitalization due to heart failure 
Yes 
No 
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Supplement 3. Number of complications discovered in the study population 
Number of complications n (%) 
Without complications 227 (46.90) 
One complication 116 (23.97) 
Two complications 75 (15.50) 
Three complications 26 (5.37) 
Four complications 26 (5.37) 
Five complications 9 (1.86) 
Six complications 3 (0.62) 
Seven complications 1 (0.21) 
Eight complications 1 (0.21) 
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